Tandem Diabetes Care Inc (TNDM) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

Total Assets Chart for Tandem Diabetes Care Inc

Tandem Diabetes Care Inc (TNDM) total assets for FY2025 were USD 881.1M, a -8.9% change from FY2024. Tandem Diabetes Care Inc's total assets grew from USD 14.0M in 2011 to USD 881.1M in 2025 (6203.7% over 14 years). Total assets compound annual growth rate: 5-year CAGR of 4.2%, 10-year CAGR of 21.6%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.21B
Implied Share Price
$17.43
Enterprise Value
$1.02B
Revenue (TTM)
$1.04B
EBITDA
-$25.03M
Profit Margin
-6.08%
Trailing P/E
—
Forward P/E
1111.11
Price/Book (MRQ)
6.65
Price/Sales (TTM)
1.16
EV/EBITDA
345.75
EV/Revenue
1.02
Dividend Yield
—
Book Value
$1.88
Free Cash Flow (FY2025)
-$29.67M
Free Cash Flow Yield
-2.45%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.